---
schema_version: "secwatch.filing_event.v1"
accession: "0001599298-22-000011"
form_type: "8-K"
ticker: "SMMT"
cik: "0001599298"
company_name: "Summit Therapeutics Inc."
filed_at: "2022-01-12T23:59:59+00:00"
generated_at: "2026-06-27T18:37:48.051072+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Summit Therapeutics VP Corporate Controller & PAO Jeffrey Maranian resigns effective Jan 21, 2022

## Summary
- Jeffrey Maranian resigned as VP Corporate Controller and Principal Accounting Officer effective Jan 21, 2022; personal decision, no disagreement with the company.
- Company plans to search for a successor for both VP Corporate Controller and Principal Accounting Officer positions.
- Maranian will assist with transition under a short-term consulting agreement.

## SEC filing metadata
- accession: 0001599298-22-000011
- form_type: 8-K
- ticker: SMMT
- cik: 0001599298
- company_name: Summit Therapeutics Inc.
- filed_at: 2022-01-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1599298/000159929822000011/0001599298-22-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1599298/000159929822000011/smmt-20220107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001599298-22-000011
- JSON: https://secwatch.observer/filing/0001599298-22-000011.json
- Plain text: https://secwatch.observer/filing/0001599298-22-000011.txt

## Key facts
- Executive change
  Jeffrey Maranian resigned as VP Corporate Controller and Principal Accounting Officer at Summit Therapeutics Inc..
  - Action: resigned
  - Role: VP Corporate Controller and Principal Accounting Officer
  source text: On January 7, 2022, Jeffrey Maranian notified Summit Therapeutics Inc. (the “Company”) that he was resigning from his positions as VP Corporate Controller and Principal Accounting Officer of the Company, effective as of close of business on January 21, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1599298/000159929822000011/0001599298-22-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.